TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: 8-hour cough counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for pharmacological support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMP‐2 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition zone score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-RNA suppression < 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CD4+ cell counts increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: risk of cancer death
Endpoint domain: Mortality/survival
Primary endpoint: Kupperman Index (KI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menopausal Rating Scale (MRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of early post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of late post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Functional mobility gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased concern about falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lipid levels decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Grading Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return of sensation to TES after tourniquet release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Return of motor function after tourniquet release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Onset of sensory anesthesia to pinprick
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 14-day case-fatality rate
Endpoint domain: Mortality/survival
Primary endpoint: Functional status improvement (MMSE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Functional status improvement (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Functional status improvement (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Active joint disease detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pulmonary complications (PPCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient experience of care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GGT activity in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical role
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Survival at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Clinical improvement (PANSS total)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical improvement (CGI-Improvement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AIx increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of PPC at 30 days postoperatively
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of RF application to achieve bidirectional conduction block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of RF energy delivery to achieve bidirectional conduction block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unsuccessful rates of surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence rates of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of the variant allele
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of smoking among doctors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol consumption rates among doctors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement in health enhancing physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FHLC-C score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HMW:LMW ADP ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical ventilation >48 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acute renal injury/failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 5-year cumulative survival rates for implants
Endpoint domain: Mortality/survival
Primary endpoint: 5-year cumulative survival rates for titanium prostheses
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of congestive heart failure (CHF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increase physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Length of non-invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cost-effectiveness (ICER per QALY)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Interleukin-6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient-rated examination difficulty
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sOB-R levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Average weight evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Survival after 2 years
Endpoint domain: Mortality/survival
Primary endpoint: urgent revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HAI titers ≥ 1:40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MN titers ≥ 1:20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total weight lost
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to respiratory hospitalization or death
Endpoint domain: Mortality/survival
Primary endpoint: Time to disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Three-year overall survival (OS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Actuarial 3-year locoregional failure risk (LRFR)
Endpoint domain: Mortality/survival
Primary endpoint: Chance of remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum 25‐OH vitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CD19 (B lymphocyte) cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bioequivalence of the new 320 mg tablet with 2 marketed 160 mg capsules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADAS-Cog score difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CIBIC+ score difference
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Immunization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants on antidepressants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Switch rates
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment response rate
Endpoint domain: Physiological/clinical
Primary endpoint: Dropout rate
Endpoint domain: Resource use
Primary endpoint: State anxiety score (STAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vigor score (POMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean seizure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-Mental State Examination (MMSE) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual analog score (VAS) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotion and complaint scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coughing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Belching score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of patients requesting medication again
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detection of serious anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in severity of obsessive-compulsive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vagina length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast self-examination frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast cancer worries
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy barriers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mortality due to bacterial sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Documented fungal infections
Endpoint domain: Adverse events/effects
Primary endpoint: integrated incremental postprandial glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: infant weight-for-age z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response to CRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reverse remodeling after CRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: moderate/severe bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Positive therapeutic relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total clinical failure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: VAS score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Face score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Depression Inventory improvements
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: worst pain experienced post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of excessive hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total blood needed during the hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood loss through drains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acute myocardial infarction cases
Endpoint domain: Adverse events/effects
Primary endpoint: Reoperation-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: UDI-6 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DFFS scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Time to achieve full enteral feedings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Efficacy of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of satisfactory sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychomotor speed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cramping during cryosurgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma glucose levels at fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma glucose levels at 2-h OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: infant bilirubin level on days 3–5 after birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glare discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Photostress recovery times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum pain during SIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance of pain-free walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of hemorrhoidal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skills gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge gains
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: intention-to-change mentoring practices
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinically relevant POPF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of drain insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: length of total hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: recurrent abscess rates
Endpoint domain: Adverse events/effects
Primary endpoint: overall charges
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in basal DNA damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in oxidative purine DNA damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in plasma lutein and beta-carotene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to bleeding cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of renal colic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Migration of the femoral stem
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: plasma low-density lipoprotein level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: integrated backscatter of IVUS-RF signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days of hemoptysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dry passes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day episode spending
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overactive bladder symptom score (OABSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary frequency per 24 hr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voided volume per micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of nocturia episodes per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum adiponectin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrent myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major or severe bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Full remission (Hamilton depression rating of 10 or lower)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe depression symptoms (BDI‐II scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of responders for signs and symptoms of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HBV specific CTL surface PD‐1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBV DNA negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HBeAg negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Good neurological outcome
Endpoint domain: Mortality/survival
Primary endpoint: oesophageal pain sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: social cognition and functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Laparoscopic skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in BMI from baseline to Year 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of colds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Deterioration of depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium or confusion during the perioperative course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete isthmus block rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intubation Time (IT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived control over pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain scores on movement at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detoxification success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved back posture knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear-avoidance beliefs
Endpoint domain: Adverse events/effects
Primary endpoint: Self-reported pain
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with complete cure of heartburn and acid regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Responder status by week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenic response to pneumococcal vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of Non-Suicidal Self-Injury (NSSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of suicide attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Postneedling soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reoperation rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean breath test result at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of abnormal exercise tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virologic response (VR) at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-op mean cardio-respiratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain and discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgeons and anaesthesiologists satisfaction criteria
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: level of bacterial adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Resolution of cutaneous SCC in situ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M-CSF secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GM-CSF secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of HBV reactivation-related hepatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Cost of prophylactic ETV treatment
Endpoint domain: Resource use
Primary endpoint: P(aO(2)) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in cataract progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Duration of symptom control
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient satisfaction with analgesic
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status